Mitochondrial genome variations are associated with amyotrophic lateral sclerosis in patients from mainland China

• Published in: Journal of neurology Vol. 269; no. 2; pp. 805 - 814
• Main Authors: Ni, Jie, Liu, Zhen, Yuan, Yanchun, Li, Wanzhen, Hu, Yiting, Liu, Pan, Hou, Xiaorong, Zhu, Xiangyu, Tang, Xuxiong, liang, Mingyu, Zheng, Siqi, Hou, Xuan, Du, Juan, Tang, Jianguang, Jiang, Hong, Shen, Lu, Tang, Beisha, Wang, Junling
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2022; Springer Nature B.V
• Subjects: Amyotrophic lateral sclerosis; Amyotrophic Lateral Sclerosis - genetics; China; DNA, Mitochondrial - genetics; Genome, Mitochondrial - genetics; Genomes; Humans; Medicine; Medicine & Public Health; Mitochondria; Mitochondrial DNA; Neurodegenerative diseases; Neurology; Neuroradiology; Neurosciences; Next-generation sequencing; Original Communication; Pathogenesis; Patients; Phenotype; Phenotypes; Polymerase chain reaction; China; Mitochondrial DNA haplogroup; Amyotrophic lateral sclerosis; Long-range polymerase chain reaction; Mitochondrial DNA variation; Whole mitochondrial genome screening
• ISSN: 0340-5354; 1432-1459
• DOI: 10.1007/s00415-021-10659-7

Background Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disorder. Mitochondrial dysfunction is involved in the complex pathophysiology of ALS; however, the role of mitochondrial DNA (mtDNA) variants in ALS is poorly understood. We aimed to elucidate the role of mtDNA variants in the pathogenesis of ALS. Methods The mitochondrial haplogroups of 585 ALS patients and 371 healthy controls were determined; 38 ALS patients and 42 controls underwent long-range polymerase chain reaction combined with next-generation sequencing technology to analyze whole mitochondrial genome variants. Results A higher percentage of variants accumulated in ALS patients than in controls. Analysis of coding region variations that were further stratified by mtDNA genes revealed that nonsynonymous variants were more vulnerable in ALS patients than in controls, particularly in the ND4L , ND5 , and ATP8 genes. Moreover, pathogenic nonsynonymous variants tended to over-represent in ALS patients. Unsurprisingly, nonsynonymous variants were not related to the phenotype. Haplogroup analysis did not found evidence of association between haplogroups with the risk of ALS, however, patients belonging to haplogroup Y and M7c were prone to develop later onset of ALS. Conclusions This is the first study to profile mtDNA variants in ALS patients from mainland China. Our results suggest that an increase in the number of nonsynonymous variants is linked to the pathogenesis of ALS. Moreover, haplogroup Y and M7c may modulate the clinical expression of ALS. Our findings provide independent, albeit limited, evidence for the role of mtDNA in the pathogenesis of ALS.